USPTO serial 86398810
AMPHITIDE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- RAPPAPORT, SETH
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AMPHITIDE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alan F. Feeney
ALAN F. FEENEY FEENEY LAW GROUP255 PROMENADE ST APT 245PROVIDENCE, RI 02908-5769UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Bacteriological consultation and research; Bacteriological research; Bacteriological research and testing; Basic and clinical research in the field of respiratory science and medicine; Biochemical research and development; Biological cloning services; Biological research; Biomedical research services; Biotechnology research; Chemical analysis; Chemical engineering; Chemical laboratories; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Chemistry consultation; Conducting clinical trials for others; Conducting clinical trials for others in the field of biotechnology; Conducting early evaluations in the field of new pharmaceuticals; Consultancy pertaining to pharmacology; Consulting in the field of drug delivery system design; Consulting in the field of biochemical engineering; Consulting services in the field of medical physics; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Cosmetics research; Cosmetics research for others; Custom design and development of chemical reagents and biochemical assays; Custom design and development of safe chemical and biological agent stimulants for use in air quality measurement; Design and testing for new product development; Design and testing of new products for others; Development and establishment of testing specifications and procedures for the pharmaceutical industry; Development and test of chemical production methods; Development of new technology for others in the field of biotechnology; Development of pharmaceutical preparations and medicines; DNA screening for scientific research purposes; Drug discovery services; Executing of chemical analyses; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Genome amplification; Genotyping services for research or analysis purposes; Innovation consulting services, namely, advising others in the areas of product development; Laboratory analysis in the field of biotechnology; Laboratory research in the field of biotechnology; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of infertility; Medical and scientific research information in the field of infertility; Medical research; Medical research services in the field of cancer; Performance of chemical analyses; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product design and development in the field of pharmaceuticals; Product development; Product development and engineering services for others; Product development consultation; Product development consulting in the field of pharmaceuticals; Product development for others; Product failure analysis services; Product quality testing; Product research; Product research and development; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research in the field of chemistry; Research in the field of infertility and reproductive science; Research on the subject of pharmaceuticals; Scientific and technological services, namely, scientific research, analysis and testing in the field of infertility and reproductive science; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research consulting in the field of cosmetics; Scientific research consulting in the field of biotechnology; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of reproductive science; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of drug delivery systems; Scientific study and research in the fields of medicinal chemistry; Testing, analysis and evaluation of the goods of others for the purpose of certification; Testing, analysis and evaluation of the services of others for the purpose of certification; Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Toxicology services; Working on and evaluation of chemical analyses; Working on and evaluation of chemical syntheses | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 11, 2016 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 11, 2016 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 9, 2015 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 14, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 14, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 25, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 9, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 9, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 6, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 6, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2015 | ALIE | ASSIGNED TO LIE | — |
| Feb 22, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 5, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 25, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 22, 2014 | NWAP | NEW APPLICATION ENTERED | — |